MOBXWMobix Labs, Inc.
The Read
7% following earnings releases and liquidity updates, reflecting investor concerns despite scenario expectations.
The schedule
- Wed30Sep
Anticipated regulatory action to cure Nasdaq minimum bid price deficiency, likely via a reverse stock split.
- Tue20Oct
Speculative announcement regarding 5G infrastructure or edge AI product cycle integrations.
- Wed18Nov
Q3 results acting as a checkpoint for cash runway validation and forward guidance.
- Sat5Dec
Macro catalyst tracking domestic semiconductor policy shifts under the current administration.
- Wed17Feb
Full-year results and strategic forward guidance dictating the company's terminal viability.
- Sat15May
Past
- Mon20Jul
Imminent catalyst regarding a highly dilutive capital raise or debt restructuring to extend runway.
- Wed20May
Actual outcome: Bear · $0.11 at outcome
Stock fell 11.7% from event to outcome date, aligning with the bear trajectory.
Q1 2026 results and commentary on cash runway and debt covenants could drive a sharp repricing of MOBXW around $0.18 on credible cost control and funding visibility, or down toward $0.18 if losses stay elevated and going-concern language intensifies.
- Wed20May
Actual outcome: Bear · $0.10 at outcome
Stock fell 11.7% from event to outcome date, aligning with the bear trajectory.
Mandatory Q2 2026 earnings catalyst to assess top-line stabilization and operating cash burn.
